Ann Ital Chir. 2021 Apr 19;10:S2239253X2103485X.
Rectal GIST is a rare tumor of the gastrointestinal tract. The few literature cases didn't show significant evidence about diagnostic and therapeutic management. We present a rare case of rectal GIST treated with laparoscopic anterior rectal resection (RARLs) preceded by neoadjuvant therapy with Imatinib Mesylate (IM).
A 68-year-old woman with abdominal pain, rectal bleeding and palpable mass on rectal exam has been subjected to computerized tomography (CT) of the abdomen and pelvis and magnetic resonance imaging (MRI) that revealed a rectal GIST of 5x4x2 cm at 3 cm from anal verge. The diagnosis was confirmed with colonoscopy. After 3- mounts neoadjuvant therapy with IM, which allowed to down-stage the neoformation, the patient underwent RARLs without intraoperative or postoperative complications. Immunohistochemistry revealed cluster of differentiation CD 117 positive, HPF 5/50, Ki 67overexpressed. PDGF mutation was detected. The patient was therefore taken in charge by the oncologist.
Resection appear curative for rectal GIST. Extensive resections aren't necessary because of downstaging after IM therapy. However, the appropriate surgical technique is still debated. Further studies are necessary for a correct surgical standardization.
Rectal GIST, Cajal cell, Laparoscopic rectal resection, Imatinib.
直肠 GIST 是一种罕见的胃肠道肿瘤。少数文献病例并未提供关于诊断和治疗管理的明确证据。我们报告了一例接受新辅助治疗伊马替尼(IM)后行腹腔镜直肠前切除术(RARLs)治疗的直肠 GIST 罕见病例。
一名 68 岁女性因腹痛、直肠出血和直肠检查可触及肿块,接受了腹部和骨盆计算机断层扫描(CT)和磁共振成像(MRI)检查,结果显示距肛门 3cm 处有 5x4x2cm 的直肠 GIST。通过结肠镜检查确诊。经过 3 个月的 IM 新辅助治疗,使新形成的肿瘤降级后,患者无术中或术后并发症地接受了 RARLs。免疫组织化学显示 CD117 阳性簇分化,高倍镜视野(HPF)5/50,Ki67 过度表达。检测到血小板衍生生长因子(PDGF)突变。因此,患者由肿瘤学家负责治疗。
直肠 GIST 的切除似乎具有治愈性。由于 IM 治疗后的降级,不需要广泛切除。然而,适当的手术技术仍存在争议。需要进一步的研究来实现正确的手术标准化。
直肠 GIST、Cajal 细胞、腹腔镜直肠切除术、伊马替尼